Stock ORY ORYZON GENOMICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Oryzon Genomics S.A.

Equities

ORY

ES0167733015

Real-time Estimate Tradegate
Other stock markets
 09:24:47 2024-05-09 am EDT 		5-day change 1st Jan Change
1.965 EUR -0.25% Intraday chart for Oryzon Genomics S.A. +3.14% +4.34%
May. 06 Oryzon Genomics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 22 Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ORYZON GENOMICS S.A.
Other Biotechnology & Medical Research
0.00%+3.14%+4.34%-6.64%-50.56% 122M
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. ORY Stock
  4. Charts Oryzon Genomics S.A.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW